Not Just an Anybody in Antibodies
Each week, we select the most interesting Jewish obituary. This week, it’s that of Dr. Ralph M. Steinman, who died at 68 of pancreatic cancer (the same thing that claimed Steve Jobs) mere days before the committee in Oslo named him one of this year’s three recipients of the Nobel Prize in Medicine. (Because the committee was unaware of his death, the prize, which is not permitted to be awarded posthumously, will still go to him.) A Jew, Montreal born, he attended the Harvard of Canada, McGill, and then Harvard. Though he won the Nobel for making among the most basic insights into immunology, such as how the immune system mobilizes to fight infection, some of his more advanced studies extended to treatment of ailments like AIDS and cancer; he was receiving experimental treatment based on his own science.
The ‘price tag’ and actual attacks are putting Israel in danger
Daily rate: $2
Monthly rate: $18
Yearly rate: $180
WAIT, WHY DO I HAVE TO PAY TO COMMENT?
Tablet is committed to bringing you the best, smartest, most enlightening and entertaining reporting and writing on Jewish life, all free of charge. We take pride in our community of readers, and are thrilled that you choose to engage with us in a way that is both thoughtful and thought-provoking. But the Internet, for all of its wonders, poses challenges to civilized and constructive discussion, allowing vocal—and, often, anonymous—minorities to drag it down with invective (and worse). Starting today, then, we are asking people who'd like to post comments on the site to pay a nominal fee—less a paywall than a gesture of your own commitment to the cause of great conversation. All proceeds go to helping us bring you the ambitious journalism that brought you here in the first place.
I NEED TO BE HEARD! BUT I DONT WANT TO PAY.
Readers can still interact with us free of charge via Facebook, Twitter, and our other social media channels, or write to us at firstname.lastname@example.org. Each week, we’ll select the best letters and publish them in a new letters to the editor feature on the Scroll.
We hope this new largely symbolic measure will help us create a more pleasant and cultivated environment for all of our readers, and, as always, we thank you deeply for your support.